牛牛AI助理已提取核心訊息
Vertex Pharmaceuticals Inc. officer Bastiano Sanna is set to sell 4,002 shares of common stock on 02/20/2024, with an aggregate market value of approximately $1,684,001.58. The shares to be sold were recently acquired on 02/17/2024 as part of compensation in the form of performance shares and restricted stock vesting, both from the issuer. This transaction follows a previous sale of 3,145 shares within the past three months, which had gross proceeds of $1,316,305.52. The planned sale is in accordance with a trading plan adopted on 08/25/2023.
Vertex Pharmaceuticals Inc. officer Bastiano Sanna is set to sell 4,002 shares of common stock on 02/20/2024, with an aggregate market value of approximately $1,684,001.58. The shares to be sold were recently acquired on 02/17/2024 as part of compensation in the form of performance shares and restricted stock vesting, both from the issuer. This transaction follows a previous sale of 3,145 shares within the past three months, which had gross proceeds of $1,316,305.52. The planned sale is in accordance with a trading plan adopted on 08/25/2023.
Vertex Pharmicals Inc.高管巴斯蒂亞諾·桑納定於2024年2月20日出售4,002股普通股，總市值約爲1,684,001.58美元。擬出售的股票最近於2024年2月17日以績效股和限制性股票歸屬的形式從發行人手中收購，作爲補償的一部分。該交易是在過去三個月內出售3,145股股票之後進行的，總收益爲1,316,305.52美元。計劃中的出售符合2023年8月25日通過的交易計劃。
Vertex Pharmicals Inc.高管巴斯蒂亞諾·桑納定於2024年2月20日出售4,002股普通股，總市值約爲1,684,001.58美元。擬出售的股票最近於2024年2月17日以績效股和限制性股票歸屬的形式從發行人手中收購，作爲補償的一部分。該交易是在過去三個月內出售3,145股股票之後進行的，總收益爲1,316,305.52美元。計劃中的出售符合2023年8月25日通過的交易計劃。
有用
沒用
該公告為獨立文件：